Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ABIRATERONE ACETATE

02 1ANASTROZOLE

03 2APIXABAN

04 2BENDAMUSTINE HYDROCHLORIDE

05 2BOSENTAN (BOSENTAN MONOHYDRATE)

06 2CETIRIZINE HYDROCHLORIDE

07 5CITALOPRAM (CITALOPRAM HYDROBROMIDE)

08 2DONEPEZIL HYDROCHLORIDE

09 1ERIBULIN MESYLATE

10 3ERLOTINIB (ERLOTINIB HYDROCHLORIDE)

11 2ESCITALOPRAM (ESCITALOPRAM OXALATE)

12 3EVEROLIMUS

13 1GEFITINIB

14 1GRANISETRON (GRANISETRON HYDROCHLORIDE)

15 2IMATINIB (IMATINIB MESYLATE)

16 4LANTHANUM (LANTHANUM CARBONATE DIHYDRATE)

17 6LENALIDOMIDE

18 1LETROZOLE

19 3LEVETIRACETAM

20 3MONTELUKAST (MONTELUKAST SODIUM)

21 1OMEPRAZOLE (OMEPRAZOLE MAGNESIUM)

22 2ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)

23 4OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

24 4POMALIDOMIDE

25 6PREGABALIN

26 5QUETIAPINE (QUETIAPINE FUMARATE)

27 2RIZATRIPTAN (RIZATRIPTAN BENZOATE)

28 1TENOFOVIR DISOPROXIL FUMARATE

29 1TERIFLUNOMIDE

30 1ZOLMITRIPTAN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : NAT-ABIRATERONE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-ABIRATERONE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-ABIRATERONE

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number : 2494132

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Brand Name : NAT-ANASTROZOLE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-ANASTROZOLE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-ANASTROZOLE

Dosage Strength : 1MG

Packaging : 30

Approval Date :

Application Number : 2417855

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Brand Name : NAT-APIXABAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-APIXABAN

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-APIXABAN

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2492814

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Brand Name : NAT-APIXABAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-APIXABAN

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-APIXABAN

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2492822

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Brand Name : NAT-BENDAMUSTINE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-BENDAMUSTINE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : POWDER FOR SOLUTION

Brand Name : NAT-BENDAMUSTINE

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 2496887

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Brand Name : NAT-BENDAMUSTINE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-BENDAMUSTINE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : POWDER FOR SOLUTION

Brand Name : NAT-BENDAMUSTINE

Dosage Strength : 100MG/VIAL

Packaging :

Approval Date :

Application Number : 2496895

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Brand Name : NAT-BOSENTAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-BOSENTAN

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-BOSENTAN

Dosage Strength : 62.5MG

Packaging : 06/10/1960

Approval Date :

Application Number : 2467984

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Brand Name : NAT-BOSENTAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-BOSENTAN

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-BOSENTAN

Dosage Strength : 125MG

Packaging : 4/14/60

Approval Date :

Application Number : 2467992

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Brand Name : NAT-CETIRIZINE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-CETIRIZINE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-CETIRIZINE

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2496461

Regulatory Info : OTC

Registration Country : Canada

blank

10

Brand Name : NAT-CETIRIZINE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAT-CETIRIZINE

arrow
2024 ACI Convention
Not Confirmed

Natco Pharma (Canada) Inc

Dosage Form : TABLET

Brand Name : NAT-CETIRIZINE

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number : 2496488

Regulatory Info : Prescription

Registration Country : Canada

blank